Adverse Drug Reactions Associated With Longer All-Oral MDR/XDR-TB Regimens: Prospective Pharmacovigilance Evidence From a High-Burden Tertiary Care Setting in North India.
发表日期: 2026-07-13
The Annals of pharmacotherapy
Medical Digest 收录日: 2026-07-14
This study evaluated the safety profile of longer all-oral regimens for multidrug-resistant (MDR) and extensively drug-resistant tuberculosis (XDR-TB) in India. A total of 102 patients were enrolled, achieving a treatment success rate of 77.5%. The study reported 158 adverse drug reactions (ADRs)...
在PubMed上阅读